West Offers Patients Even More Oncology Treatment Options

MEMPHIS, Tenn., Oct. 22, 2020 /PRNewswire-PRWeb/ — As an affiliate of OneOncology, West Cancer Center & Research Institute now has the ability to further its clinical trial offerings and oncology research knowledge by joining the launch of OneR.

OneR is a new, unprecedented technology platform and collaboration throughout the OneOncology network that provides seamless clinical trial management, increased access to trial therapies for patients, and more oncology research information readily available to our clinicians. Patients can participate in clinical trials for specific cancer types, in an effort to decrease side effects of current treatments, or with aims to improve disease outcomes – and now, with the implementation of OneR, these efforts are supported more than ever before.

Mitch Graves, CEO of West Cancer Center states, “We are incredibly excited to join the launch of OneR! This new platform allows us to offer more clinical trials to patients in need by centralizing business functions, regulatory submissions, and clinical trial matching technology while also maintaining our flexibility to participate in other clinical trial initiatives managed by our in-house Clinical Research Department. It’s an exciting time for cancer research, and this new initiative will give our patients and their families more treatment options than ever before!”

Recently, West added “Research Institute” to its name to ensure the priority and focus it has on clinical research was made apparent and embedded into its culture. This new opportunity only further promotes its many initiatives to increase oncology research across the globe.

 

SOURCE West Cancer Center

Staff

Recent Posts

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…

3 hours ago

Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship

The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…

6 hours ago

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…

6 hours ago

KLAS Report Shows Strong Early Results for TrustCommerce Cloud Payments

CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…

6 hours ago

BioFlorida Announces Appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of the Southeast Chapter

MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…

6 hours ago

Truemed Closes $34 Million Series A To Unlock HSA/FSA Funds For Lifestyle Interventions

Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…

6 hours ago